Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-bound transcription factors that regulate lipid homeostasis. They control the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids. Activation involves proteolytic cleavage and translocation to the nucleus to upregulate target genes. Dysregulation is implicated in metabolic diseases and cancer, making them potential therapeutic targets.
Inhibition of SREBP activation or downstream target gene expression
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol Regulatory Element-Binding Protein (SREBP).